We are trying to tackle really hard problems. What makes our audacious goals feel achievable is our inspirational team that is working to solve those problems.
As founder and CEO of SHINE Technologies, Greg has nearly 20 years of executive management experience at growth-stage technology companies. His passion is the growth of technology companies that take scientific advancement to commercialization, providing the opportunity to serve and better humanity. Greg holds a PhD in nuclear engineering and BS degrees in physics and electrical and computer engineering from the University of Wisconsin–Madison.
Todd joined SHINE in September 2015 and served as chief financial officer from 2018 to 2021. As chief strategy officer he helps guide the strategic execution of SHINE’s vision, while his team facilitates a variety of corporate functions such as Legal, Investor Relations and Marketing & Communications. Prior to SHINE, Todd took multiple venture-capital-backed companies from concept to commercialization to profitability using lean startup, customer-focused product development techniques. Todd earned an M.B.A. from the Kellogg School of Management at Northwestern University and a bachelor’s in mechanical engineering from Yale University.
Harrie oversees business aspects of SHINE's therapeutic and diagnostic medical isotopes businesses, including strategic partnerships, global sales relationships, market research, and more. Before joining SHINE, Harrie was chief operating officer and then managing director of NRG, an international nuclear service provider, in the Netherlands. Among other things, he oversaw all nuclear installations, including the Dutch High Flux medical isotope production facility. He studied applied physics at the University of Groningen.
Tom joined us as CEO of Phoenix LLC, which operates the industrial imaging arm of the business, representing Phase 1 of SHINE’s business. Tom brings more than two decades of experience in sales leadership roles for start-ups, emerging, and established companies across health care, biotech and software industries. Tom holds a bachelor’s degree in chemistry from Loyola University of Chicago and an MBA from Vanderbilt University with concentrations in marketing and finance.
With nine years of experience in the definition, planning and implementation of technically rigorous projects, Jessica serves as COO for SHINE’s Systems and Therapeutics divisions. She previously was responsible for leading production and planning, testing, and building of SHINE’s core fusion systems. Jessica holds a BS in Physics from the University of Wisconsin.
Chris has served as our Chief Financial Officer since 2021. As CFO, Chris is responsible for steering the company’s strategy to ensure we maintain a strong financial position while delivering long-term, sustainable value to our shareholders. Chris joined SHINE in 2016, and prior to his appointment to CFO, served as our Vice President of Finance from 2018-2021. Prior to joining us, Chris spent five years with Kimberly-Clark in various finance and supply chain positions. He received his B.B.A. in Business from the University of Wisconsin-Madison.
As Vice President of Research & Development, Eli oversees research efforts across all SHINE business units, supporting both scientific projects and prototype development aligned to SHINE’s technical vision. With 10+ years of experience, he previously served as R&D Manager, overseeing nuclear physics and data science. Eli holds a Ph.D. in Nuclear Engineering from the University of Wisconsin – Madison, with a focus on adjoint thermal neutronics, computational radiation transport, and statistical analysis.
As CPO, Ben guides both our Human Resources and Information Technology teams. Ben brings nearly three decades of executive experience to SHINE, with a proven track record in market-based management, vision and strategy development, change management, supply chain excellence, innovation, emerging technologies, leadership development, commodities derivatives trading, and quantitative analysis. Previously with Koch Industries, Ben held various roles, including Chief Information Officer and Chief Operating Officer, across multiple Koch companies.
As CTO, Ross is focused on leading technology development in all aspects of SHINE’S mission. Radel has more than 20 years of research and development experience on a variety of fusion, fission, and particle accelerator technologies that are directly applicable to SHINE’s core technologies. His PhD research at the University of Wisconsin focused on high-flux neutron generation for detecting clandestine material, specifically highly enriched uranium. Ross is an expert in radiation transport simulations and he has experience designing shielding, moderators, and reflectors for high-neutron environments.
Eric joined SHINE as the chief of staff & vice president of government affairs, responsible for planning and leading SHINE’s strategic government affairs activities. Eric spent 25 years working in and around government at the state and federal levels, including serving as Governor Scott Walker’s (R-WI) chief of staff and as an SVP of External Affairs and Head of State Government Affairs with United Health Group. Schutt holds an MBA from George Washington University and a bachelor’s in History, Political Science, and International Relations from UW-Madison.
Greg is the founder and CEO of SHINE Technologies and has nearly 20 years of executive management experience at growth-stage technology companies. Before SHINE, he served as the president of Phoenix Nuclear Labs, where he managed the development of high-output particle sources. He formerly served as the chief technical officer of Gillware Inc., a leading data recovery and backup company. He holds a Ph.D. in nuclear engineering, and B.S. degrees in physics and electrical and computer engineering from the University of Wisconsin–Madison. Greg has received numerous awards and honors including the prestigious UW-Madison Early Career award, is the primary inventor on multiple patents and author or co-author of numerous publications, and serves on the boards of several profit and non-profit entities. His passion is the growth of technology companies that take scientific advancement to commercialization, providing the opportunity to serve and better humanity.
David began his career in 1980 as a law clerk for a U.S. District Court Judge in the Southern District of New York. He has extensive experience incorporate and commercial matters, intellectual property, real estate development and financing, and mergers and acquisitions, including advice and representation in the financing and securities areas, both public and private. David represents corporations and joint ventures both domestic and abroad in high technology and basic industry, acquisitions and divestitures and intellectual property matters, including licensing and distribution of high technology products and processes. In addition, David provides legal services to individuals and family businesses and their estate and succession planning issues. Among his pro bono activities, David serves on the panel of mediators for the Federal Courts in the Southern District of New York. He has also been an Adjunct Professor of Law at Pace University Law School where he taught Securities Regulation. He earned an A.B. degree from Princeton University and his J.D. degree from Columbia University.
Dr. Robertson is a seasoned corporate director and health care executive in the medical device, life science, and pharmaceutical industries. He has been a Venture Partner at Baird Capital since 2011 and retired from the anesthesiology faculty at the University of Wisconsin School of Medicine and Public Health in2018. Previously, Frederick held the role of CEO and director of TomoTherapy Inc. before that company was acquired in 2011. Prior to joining TomoTherapy, Frederick served in a variety of roles in the medical industry, including President and CEO of GE Marquette Medical Systems and later as Chief Clinical Officer of GE Medical Systems, as well as management positions with Marquette Medical Systems, including president and CEO. He served as a director of Lantheus Holdings from 2016-2021. He serves on the board of directors of the University of Wisconsin Foundation; the Morgridge Institute for Research; Virtual Incision; Saranas Inc.; Ensodata, Inc.; Elucent, Inc.; and Zurex Pharma, Inc. Frederick received his MBA from San Diego State University and earned his M.D. from University of Wisconsin Medical School.
Gordon Gunnlaugsson is a former Executive Vice President and Chief Financial Officer at Marshall & Ilsley Corporation (M&I), where he provided strategic financial leadership from 1987 to 2000. With a background in business administration and a strong commitment to philanthropy, Gordon brings a wealth of experience to SHINE's board. He is a director of FiduciaryManagement, Inc., and a member of Wisconsin Investment Partners, showcasing his continued dedication to the business community.
Holli joined SHINE’s Board of Directors in April 2022. In addition to serving as a public company CEO and CFO, she brings more than 17 years of experience across six boards. Holli has more than three decades of professional experience within the energy sector, including a strong track record in the areas of mergers and acquisitions, international operations, CEO succession and shareholder engagement. She is also well-versed in upstream oil and gas, power and specialty construction fields, as well as risk management and compliance monitoring in highly regulated businesses. Most recently, Holli served as the president and CEO of Select Energy Services, a premier provider of innovative, efficient, end-to-end water management solutions for energy producers. From2011-2017, she rose to be president and CEO of Rockwater Energy Solutions, which she carried through to a merger with Select Energy Services in November 2017. Holli held her posts with Select until January 2021. She also spent more than a decade with Dynegy, Inc., a certified retail electric service provider, including serving as executive vice president and CFO. Holli currently serves on the boards for Quanta Services, Priority Power and Marathon Oil Company, as well as the Rice University Board of Trustees and the Junior Achievement ofSouthwest Texas. Holli holds a bachelor’s degree in accounting from BaylorUniversity and a MBA from Rice University.
Paul was the 54th Speaker of the U.S. House of Representatives. He was the youngest speaker in nearly 150 years. During his tenure, Paul spearheaded efforts to reform our nation’s tax code, rebuild our national defense, expand domestic energy production, combat the opioid epidemic, reform our criminal justice system, and promote economic opportunity. As Chairman of the House Ways and Means Committee, he worked to protect health care choices, advance free trade and strengthen the economy. Paul also served as Chairman of the House Budget Committee. In 2012, he was selected to serve as his party’s vice-presidential nominee. Paul was elected to Congress at age 28 and represented Wisconsin’s First District for two decades. He serves on the board of directors of the Fox Corp. He was named a Professor-of-the-Practice at the University of Notre Dame for the 2019-2020 academic year. He holds a bachelor’s degree in economics and political science from Miami University in Ohio and was awarded an honorary doctorate by the university.
Ray Rothrock is a seasoned venture capitalist, tech investor, and cyber security expert with a distinguished track record in early-stage technology investments. During his tenure as a partner at Venrock, he invested in over 50 early-stage technology companies and achieved 9 IPOs, earning recognition on the Forbes Midas List several times. Ray is currently the founder of FiftySix Investments LLC, specializing in cyber, energy, and sustainability investments. His extensive background in nuclear engineering, coupled with his business acumen, makes him a valuable addition to SHINE's board.
Sue Marks is an accomplished serial entrepreneur, CEO, board member and investor with experience in the tech and tech-enabled services sectors. Most recently she founded and served as CEO of Cielo, the leading global talent acquisition partner, providing Recruitment and Total Workforce Solutions, where she remains a member of the company’s board. Sue's entrepreneurial spirit, business acumen, and leadership in the technology and business sectors will bring invaluable insights to SHINE.
Dr. Mackie is an Emeritus Professor in the departments of Medical Physics, Human Oncology, and Engineering Physics at the University of Wisconsin–Madison and serves as the board chair for the UW Health Isthmus Project. He is the author of more than 180 peer-reviewed publications, 50 patents, and has supervised more than 40 Ph.D. students. In 2021, Rock was named National Academy of Inventors fellow, the highest professional distinction given to academic inventors, in recognition of his accomplishments. With his expertise in radiation therapy treatment planning and intensity-modulated radiotherapy, his group developed the PinnacleTM treatment planning system, now marketed by Philips Medical. He was a co-founder and Chairman of the Board of TomoTherapy,Inc., a Madison-based public company (NASDQ: TOMO) that employed 650 people. Rock received his bachelor’s in Physics from the University of Saskatchewan in 1980 and his Ph.D. in Physics from the University of Alberta in 1984.
James is executive vice president of C3 Energy, which offers big data energy analytics solutions to utilities and to oil and gas companies. Prior to joining C3 Energy, he served as executive vice president and senior policy advisor of Exelon Corp., and executive vice president, corporate affairs, public and environmental policy for Constellation Energy. From 2001-09, James was chairman of the White House Council on Environmental Quality. In this capacity, he served on President Bush’s staff as Senior Environment, Energy andNatural Resources Advisor and as Director of the White House Office ofEnvironmental Policy. He holds a bachelor’s degree from Yale University and aJ.D. from Northwestern University School of Law.
Scott is the managing director of public affairs at the national law firm of Foley & Lardner LLP. He chairs the firm’s client service team. For eight years, Scott represented Madison, Wisconsin, in the U.S. House of Representatives, where he developed an expertise in health care, energy policy and financial services. He was appointed by President Bush for two terms to the Advisory Committee to the United States Trade Representative. Prior to his election to Congress, he was an Emmy award-winning reporter and anchor in Washington, D.C., Seattle, and his native Wisconsin. Scott is a novelist whose freelance writing has appeared in a number of U.S. newspapers and magazines. Before he joined Foley, he founded a regional magazine and book publishing company, which he sold in 2007. Klug holds an M.B.A. in finance from the University of Wisconsin, a master’s degree in journalism from Northwestern and a bachelor’s from Lawrence University.
Christopher is a results-oriented, innovative executive with 35 years of comprehensive U.S. and international expertise in nuclear medicine and medical isotope production. A longtime veteran of Amersham Health and GE Healthcare, he has launched core products, expanded products internationally, led the design, construction and FDA approval of two new U.S. manufacturing facilities, and held responsibility for several full-GMP radiopharmaceutical manufacturing sites across the United States and Europe. Before his retirement in 2008, Christopher served as general manager of global nuclear medicine supply chain for GEHealthcare, and general manager of Oncura, GE’s global I-125 brachytherapy seeds business. He has an impeccable track record of operational excellence, continuous profitability improvement, and implementation of industry-leading quality systems.
Donald is the managing member of DJW Advisors, providing advisory services to institutional and high-net-worth clients. He has worked for more than 30 years in energy and financial services, providing valuation and advisory services and most recently supporting clients investing in other industry sectors including mining and biotech. After graduating with a bachelor’s in accounting from Clarkson University, Donald began his professional career as an auditor for Arthur Andersen. His career has included accounting, finance and acquisition work for companies involved in oil and gas, agricultural biotech, broker dealer and syndication of real estate investments and energy consulting. In addition to being an advisor of SHINE, Donald has also served as a director of Phoenix Nuclear Labs, a private manufacturer of commercial neutron generators; a director of GeoResources Inc., a Houston, Texas-based publicly traded exploration & production company; board observer of Flugen, Inc., a private biotech company producing novel vaccines; and Director and Chief financial officer for JS Herold, Inc an oil and gas consulting firm.
Brad is president of Baker Construction Enterprises, Inc. Prior to joining Baker in 2010, he served as CEO of Phillips-Medisize, a global leader in outsource design, development, and technology-driven manufacturing for drug delivery, medical device, and medical diagnostic products. Brad served as the executive vice president and chief operating officer of Schwing America, Inc., a member of the Schwing Group, a worldwide designer, manufacturer and distributor of concrete production and handling equipment. His career began with Ernst & Young in Minnesota, where he performed client audits as a CPA. After his time in public accounting, he served as the director of international finance for Synder General Corp., a designer and manufacturer of commercial and industrial air conditioning and handling equipment. Brad has a degree in finance and accounting from the University of Wisconsin-Madison and holds an MBA from the University of Minnesota. He has served on numerous boards in the construction, manufacturing, and medical technology industries.
We stand apart from other fusion companies because we have commercialized fusion today and we are scaling our technology. During each of our four phases, we’re perfecting core competencies needed for commercially viable fusion, producing useful products, building shareholder value, and reinvesting in future growth.
Join us and be part of the solution.
